Physician profile
Mark Gerald Brooks
NPI 1306927249
$921.76
in general payments reported to CMS, 2019-2025
22 companies · $40.82 in 2025
The $40.82 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $230 · 2021: $131 · 2022: $12.80 · 2024: $27.26 · 2025: $40.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $68.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $68.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $170.38 | 2019 | |
| Pfizer INC. | $136.45 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $90.36 | 2019-2020 | |
| Novo Nordisk INC | $51.40 | 2019-2020 | |
| Exact Sciences Corporation | $40.82 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $39.00 | 2021-2022 | |
| Astellas Pharma US INC | $37.85 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $33.86 | 2021 | |
| Amgen INC. | $31.74 | 2019 | |
| Phathom Pharmaceuticals, INC. | $27.26 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $26.76 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.47 | 2019 | |
| Horizon Therapeutics Plc | $25.07 | 2019 | |
| Glaxosmithkline, LLC. | $24.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.75 | 2020-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $23.95 | 2019 | |
| Sunovion Pharmaceuticals INC. | $23.41 | 2021 | |
| Sanofi-Aventis U.S. LLC | $22.19 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.92 | 2021 | |
| Acclarent, INC | $17.25 | 2019 | |
| Hologic Sales and Service, LLC | $13.98 | 2019 | |
| Clarus Therapeutics INC. | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.